Enanta Pharmaceuticals Inc. buy Jefferies Financial Group Inc.
Start price
01.10.25
/
50%
€9.05
Target price
01.10.26
€17.04
Performance (%)
52.49%
Price
23.12.25
€13.10
Summary
This prediction is currently active. With a performance of 52.49% the BUY prediction by Jefferies_Financial_ is a big success. This prediction currently runs until 01.10.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | 10.084% | 10.084% |
| iShares Core DAX® | 1.732% | 4.638% |
| iShares Nasdaq 100 | 3.304% | 0.517% |
| iShares Nikkei 225® | 2.342% | 0.972% |
| iShares S&P 500 | 2.357% | 0.872% |
Comments by Jefferies_Financial_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.05
01.10.25
01.10.25
€17.04
01.10.26
01.10.26
52.49%
23.12.25
23.12.25

